Skip to main content
PMC home page
British Heart Journal logoLink to British Heart Journal
. 1988 Oct;60(4):309–315. doi: 10.1136/hrt.60.4.309

Long term doxorubicin cardiotoxicity in childhood: non-invasive evaluation of the contractile state and diastolic filling.

G Hausdorf 1, G Morf 1, G Beron 1, R Erttmann 1, K Winkler 1, G Landbeck 1, E W Keck 1
PMCID: PMC1216578  PMID: 3190959

Abstract

Cardiac performance was evaluated at least two years after doxorubicin treatment in childhood in 55 patients without overt congestive cardiomyopathy. None of the patients had received mediastinal irradiation. Computer-assisted analysis of digitised echocardiograms showed impaired rapid diastolic filling and an increased change of dimension between minimal cavity dimension and mitral valve opening. This impairment of diastolic function was related to the cumulative dose of doxorubicin. In contrast when angiotensin II was infused to increase the afterload the end systolic pressure-length and stress-shortening relation indicated normal left ventricular systolic function. But during baseline conditions the end systolic wall stress was significantly increased in patients in whom the cumulative dose of doxorubicin exceeded 360 mg/m2.

Full text

PDF
309

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Billingham M. E., Mason J. W., Bristow M. R., Daniels J. R. Anthracycline cardiomyopathy monitored by morphologic changes. Cancer Treat Rep. 1978 Jun;62(6):865–872. [PubMed] [Google Scholar]
  2. Borow K. M., Arensman F. W., Webb C., Radley-Smith R., Yacoub M. H. Assessment of left ventricular contractile state after anatomic correction of transposition of the great arteries. Circulation. 1984 Jan;69(1):106–112. doi: 10.1161/01.cir.69.1.106. [DOI] [PubMed] [Google Scholar]
  3. Borow K. M., Green L. H., Grossman W., Braunwald E. Left ventricular end-systolic stress-shortening and stress-length relations in human. Normal values and sensitivity to inotropic state. Am J Cardiol. 1982 Dec;50(6):1301–1308. doi: 10.1016/0002-9149(82)90467-2. [DOI] [PubMed] [Google Scholar]
  4. Borow K. M., Henderson I. C., Neuman A., Colan S., Grady S., Papish S., Goorin A. Assessment of left ventricular contractility in patients receiving doxorubicin. Ann Intern Med. 1983 Dec;99(6):750–756. doi: 10.7326/0003-4819-99-6-750. [DOI] [PubMed] [Google Scholar]
  5. Borow K. M., Newburger J. W. Noninvasive estimation of central aortic pressure using the oscillometric method for analyzing systemic artery pulsatile blood flow: comparative study of indirect systolic, diastolic, and mean brachial artery pressure with simultaneous direct ascending aortic pressure measurements. Am Heart J. 1982 May;103(5):879–886. doi: 10.1016/0002-8703(82)90403-3. [DOI] [PubMed] [Google Scholar]
  6. Bristow M. R., Mason J. W., Billingham M. E., Daniels J. R. Doxorubicin cardiomyopathy: evaluation by phonocardiography, endomyocardial biopsy, and cardiac catheterization. Ann Intern Med. 1978 Feb;88(2):168–175. doi: 10.7326/0003-4819-88-2-168. [DOI] [PubMed] [Google Scholar]
  7. Brodie B. R., McLaurin L. P., Grossman W. Combined hemodynamic-ultrasonic method for studying left ventricular wall stress: comparison with angiography. Am J Cardiol. 1976 May;37(6):864–870. doi: 10.1016/0002-9149(76)90111-9. [DOI] [PubMed] [Google Scholar]
  8. Chen W., Gibson D. Relation of isovolumic relaxation to left ventricular wall movement in man. Br Heart J. 1979 Jul;42(1):51–56. doi: 10.1136/hrt.42.1.51. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Colan S. D., Borow K. M., Neumann A. Left ventricular end-systolic wall stress-velocity of fiber shortening relation: a load-independent index of myocardial contractility. J Am Coll Cardiol. 1984 Oct;4(4):715–724. doi: 10.1016/s0735-1097(84)80397-6. [DOI] [PubMed] [Google Scholar]
  10. Ewer M. S., Ali M. K., Mackay B., Wallace S., Valdivieso M., Legha S. S., Benjamin R. S., Haynie T. P. A comparison of cardiac biopsy grades and ejection fraction estimations in patients receiving Adriamycin. J Clin Oncol. 1984 Feb;2(2):112–117. doi: 10.1200/JCO.1984.2.2.112. [DOI] [PubMed] [Google Scholar]
  11. Gilladoga A. C., Manuel C., Tan C. T., Wollner N., Sternberg S. S., Murphy M. L. The cardiotoxicity of adriamycin and daunomycin in children. Cancer. 1976 Feb;37(2 Suppl):1070–1078. doi: 10.1002/1097-0142(197602)37:2+<1070::aid-cncr2820370814>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  12. Goldberg S. J., Hutter J. J., Jr, Feldman L., Goldberg S. M. Two sensitive echocardiographic techniques for detecting doxorubicin toxicity. Med Pediatr Oncol. 1983;11(3):172–177. doi: 10.1002/mpo.2950110308. [DOI] [PubMed] [Google Scholar]
  13. Goorin A. M., Borow K. M., Goldman A., Williams R. G., Henderson I. C., Sallan S. E., Cohen H., Jaffe N. Congestive heart failure due to adriamycin cardiotoxicity: its natural history in children. Cancer. 1981 Jun 15;47(12):2810–2816. doi: 10.1002/1097-0142(19810615)47:12<2810::aid-cncr2820471210>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  14. Gottdiener J. S., Mathisen D. J., Borer J. S., Bonow R. O., Myers C. E., Barr L. H., Schwartz D. E., Bacharach S. L., Green M. V., Rosenberg S. A. Doxorubicin cardiotoxicity: assessment of late left ventricular dysfunction by radionuclide cineangiography. Ann Intern Med. 1981 Apr;94(4 Pt 1):430–435. doi: 10.7326/0003-4819-94-4-430. [DOI] [PubMed] [Google Scholar]
  15. Hanrath P., Mathey D. G., Siegert R., Bleifeld W. Left ventricular relaxation and filling pattern in different forms of left ventricular hypertrophy: an echocardiographic study. Am J Cardiol. 1980 Jan;45(1):15–23. doi: 10.1016/0002-9149(80)90214-3. [DOI] [PubMed] [Google Scholar]
  16. Hausdorf G., Gluth J., Nienaber C. A. Non-invasive assessment of end-systolic pressure-length and stress-shortening relationships in normal individuals: significance of different loading conditions induced by methoxamine and angiotensin II. Eur Heart J. 1987 Oct;8(10):1099–1108. doi: 10.1093/oxfordjournals.eurheartj.a062175. [DOI] [PubMed] [Google Scholar]
  17. Lang R. M., Borow K. M., Neumann A., Janzen D. Systemic vascular resistance: an unreliable index of left ventricular afterload. Circulation. 1986 Nov;74(5):1114–1123. doi: 10.1161/01.cir.74.5.1114. [DOI] [PubMed] [Google Scholar]
  18. Mason J. W., Bristow M. R., Billingham M. E., Daniels J. R. Invasive and noninvasive methods of assessing adriamycin cardiotoxic effects in man: superiority of histopathologic assessment using endomyocardial biopsy. Cancer Treat Rep. 1978 Jun;62(6):857–864. [PubMed] [Google Scholar]
  19. Mortensen S. A., Olsen H. S., Baandrup U. Chronic anthracycline cardiotoxicity: haemodynamic and histopathological manifestations suggesting a restrictive endomyocardial disease. Br Heart J. 1986 Mar;55(3):274–282. doi: 10.1136/hrt.55.3.274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Pegelow C. H., Popper R. W., de Wit S. A., King O. Y., Wilbur J. R. Endomyocardial biopsy to monitor anthracycline therapy in children. J Clin Oncol. 1984 May;2(5):443–446. doi: 10.1200/JCO.1984.2.5.443. [DOI] [PubMed] [Google Scholar]
  21. Pratt C. B., Ransom J. L., Evans W. E. Age-related adriamycin cardiotoxicity in children. Cancer Treat Rep. 1978 Sep;62(9):1381–1385. [PubMed] [Google Scholar]
  22. Sagawa K., Suga H., Shoukas A. A., Bakalar K. M. End-systolic pressure/volume ratio: a new index of ventricular contractility. Am J Cardiol. 1977 Nov;40(5):748–753. doi: 10.1016/0002-9149(77)90192-8. [DOI] [PubMed] [Google Scholar]
  23. Sagawa K. The end-systolic pressure-volume relation of the ventricle: definition, modifications and clinical use. Circulation. 1981 Jun;63(6):1223–1227. doi: 10.1161/01.cir.63.6.1223. [DOI] [PubMed] [Google Scholar]
  24. Sahn D. J., DeMaria A., Kisslo J., Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978 Dec;58(6):1072–1083. doi: 10.1161/01.cir.58.6.1072. [DOI] [PubMed] [Google Scholar]
  25. Stefadouros M. A., Dougherty M. J., Grossman W., Craige E. Determination of systemic vascular resistance by a noninvasive technic. Circulation. 1973 Jan;47(1):101–107. doi: 10.1161/01.cir.47.1.101. [DOI] [PubMed] [Google Scholar]
  26. Stein E., Hanrath P., Bleifeld W., Garbrecht M., Müllerleile U. Abnormes Kontraktions- und Füllverhalten des linken Ventrikels bei Tumorpatienten unter Adriamycin-Therapie. Eine echokardiographische Studie. Dtsch Med Wochenschr. 1978 Sep 8;103(36):1408–1412. doi: 10.1055/s-0028-1129273. [DOI] [PubMed] [Google Scholar]
  27. Tyberg T. I., Goodyer A. V., Hurst V. W., 3rd, Alexander J., Langou R. A. Left ventricular filling in differentiating restrictive amyloid cardiomyopathy and constrictive pericarditis. Am J Cardiol. 1981 Apr;47(4):791–796. doi: 10.1016/0002-9149(81)90175-2. [DOI] [PubMed] [Google Scholar]
  28. Upton M. T., Gibson D. G. The study of left ventricular function from digitized echocardiograms. Prog Cardiovasc Dis. 1978 Mar-Apr;20(5):359–384. doi: 10.1016/0033-0620(78)90003-8. [DOI] [PubMed] [Google Scholar]
  29. Weber K. T., Janicki J. S. The dynamics of ventricular contraction: force, length, and shortening. Fed Proc. 1980 Feb;39(2):188–195. [PubMed] [Google Scholar]
  30. Young R. C., Ozols R. F., Myers C. E. The anthracycline antineoplastic drugs. N Engl J Med. 1981 Jul 16;305(3):139–153. doi: 10.1056/NEJM198107163050305. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES